GlassScriptPhysician profile
Nicole Yvonne Larson
NPI 1386375905
$417.65
in general payments reported to CMS, 2019-2025
9 companies · $84.48 in 2025
The $84.48 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $67.47 · 2023: $105 · 2024: $161 · 2025: $84.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $92.86 | 2022-2023 | |
| Organon LLC | $76.30 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $73.52 | 2023-2025 | Slynd |
| Sage Therapeutics, LLC | $44.58 | 2024 | |
| Shield Therapeutics INC | $36.76 | 2024 | |
| Coopersurgical, INC. | $34.25 | 2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $23.79 | 2025 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $20.60 | 2022 | |
| Pfizer INC. | $14.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.